Northwest ATTC Webinar: Outreach-Based Long-Acting Injectable Buprenorphine (Jan. 21, 2026, 12-1pm PT)
12/29/2025
Join presenters Jeremy Hoog, RN, BSN, MA, and Carson Bell, MPH of the Downtown Emergency Service Center (DESC) in Seattle, WA for the first Northwest ATTC webinar of 2026!
Outreach-Based Long-Acting Injectable Buprenorphine: A Viable Pathway to Closing OUD Treatment Gaps
January 21, 2026 (12-1pm PT)
Overdose deaths involving fentanyl increased by 45% from 2021 to 2022 in Washington State, disproportionately involving people experiencing houselessness, highlighting the urgent need to increase access to medications for opioid use disorder (MOUD) in this population.
A multidisciplinary outreach team is successfully breaking down those barriers by offering field-based long-acting injectable buprenorphine (LAI-BUP) to people with opioid use disorder in outreach settings including permanent support housing sites.
Field-based LAI-BUP injections offer a significant advantage to this population, providing a reliable and convenient long-acting option that increases sustained therapeutic OUD treatment and ultimately aiding in peoples’ continued success in housing.
Learning objectives
- Learn about buprenorphine long-acting injections and their benefits to those with opioid use disorder
- Understand the importance of advocating for creative solutions to provide better care to the people we serve when more traditional models have not been as successful
- Identify client-centered engagement strategies used by outreach teams to create better health outcomes
